Newsfiscal.ai
IceCure Medical Enrolls First Patients in FDA-Approved ChoICE Study
· Published
Article summary
IceCure Medical has officially begun patient enrollment for its post-market clinical study of the ProSense cryoablation system for breast cancer at two U.S. sites.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…